{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041362","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.789033+00:00","generated_at":"2026-05-30T13:25:07.380648+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Anebulo updates corporate presentation; no specific changes disclosed in filing extract","bullets":["Company furnished an updated Corporate Presentation as Exhibit 99.1 under Item 7.01.","Presentation content is not included in the provided text; details of updates are unknown.","No forward-looking statements or material financial data were available for review.","Investors should request the full presentation from the company for substantive changes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041362","json":"https://secwatch.observer/filing/0001493152-24-041362.json","markdown":"https://secwatch.observer/filing/0001493152-24-041362.md","text":"https://secwatch.observer/filing/0001493152-24-041362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224041362/0001493152-24-041362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000149315224041362/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:25:07.380648+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}